Prazosin 2 MG Oral Capsule — RxCUI 312594
RxNorm drug concept · Semantic clinical drug
RxCUI 312594
Semantic clinical drug · SCD
● Current RxNorm concept 76 FDA products
163 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI312594
Official namePrazosin 2 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asprazosin (as prazosin HCl) 2 MG Oral Capsule; prazosin HCl 2 MG Oral Capsule
FDA products mapped76
Package NDCs mapped163
Reported Medicaid activity (SDUD)2,024,285 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Prazosin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats high blood pressure. Bringing your pressure down lowers your risk of stroke and heart attack. It can be taken alone or with other blood pressure medicines like water pill...
- Prazosin capsules are taken by mouth, usually two or three times a day at first. Your prescriber will start you low and raise the dose slowly based on your blood pressure. Take it...
- Prazosin can drop your blood pressure quickly, especially in the first hours after a first dose or an increase. Dizziness is common, and fainting is less common. Be careful standin...
- Dizziness, headache, drowsiness, low energy, weakness, palpitations and nausea are the most common. These often fade with continued use. Call your doctor if they are bothersome or...
🕸️ Concept Web — How Prazosin 2 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Prazosin 2 MG Oral Capsule
RxCUI 312594 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Prazosin
8629IN
-
Prazosin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Minipress
71515BN
-
Minipress
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Prazosin Oral Capsule
373565SCDF -
Prazosin Oral Product
1161700SCDG -
Prazosin Pill
1161701SCDG -
Prazosin Oral Capsule [Minipress]
366692SBDF -
Minipress Oral Product
1179767SBDG -
Minipress Pill
1179768SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Prazosin Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Prazosin 2 MG
328786SCDC -
Prazosin 2 MG Oral Capsule [Minipress]
208980SBD -
Prazosin 2 MG [Minipress]
569624SBDC
-
Prazosin 2 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Prazosin 2 MG
SCDC · 328786 -
Prazosin Oral Capsule
SCDF · 373565 -
Prazosin Oral Product
SCDG · 1161700 -
Prazosin Pill
SCDG · 1161701
Brand-Name Concepts
-
Prazosin 2 MG Oral Capsule [Minipress]
SBD · 208980 -
Prazosin 2 MG [Minipress]
SBDC · 569624 -
Prazosin Oral Capsule [Minipress]
SBDF · 366692 -
Minipress Oral Product
SBDG · 1179767 -
Minipress Pill
SBDG · 1179768 -
Minipress
BN · 71515
📦 FDA Products & Package NDCs
76 products · 163 package NDCs
163 package NDCs map to RxCUI 312594 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-4067-01 | 100 CAPSULE in 1 BOTTLE (0093-4067-01) | Prazosin Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2007-02-22 |
| 00093-4067-10 | 1000 CAPSULE in 1 BOTTLE (0093-4067-10) | Prazosin Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2007-02-22 |
| 00093-4068-01 | 100 CAPSULE in 1 BOTTLE (0093-4068-01) | Prazosin Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2007-02-22 |
| 00093-4068-10 | 1000 CAPSULE in 1 BOTTLE (0093-4068-10) | Prazosin Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2007-02-22 |
| 00093-4069-01 | 100 CAPSULE in 1 BOTTLE (0093-4069-01) | Prazosin Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2007-02-22 |
| 00093-4069-05 | 500 CAPSULE in 1 BOTTLE (0093-4069-05) | Prazosin Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2007-01-18 |
| 00093-4069-52 | 250 CAPSULE in 1 BOTTLE (0093-4069-52) | Prazosin Hydrochloride | Teva Pharmaceuticals USA, Inc. | 2007-02-22 |
| 00378-1101-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1101-01) | Prazosin Hydrochloride | Mylan Pharmaceuticals Inc. | 1989-02-28 |
| 00378-1101-10 | 1000 CAPSULE in 1 BOTTLE, PLASTIC (0378-1101-10) | Prazosin Hydrochloride | Mylan Pharmaceuticals Inc. | 1989-02-28 |
| 00378-2302-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-2302-01) | Prazosin Hydrochloride | Mylan Pharmaceuticals Inc. | 1989-02-28 |
| 00378-2302-10 | 1000 CAPSULE in 1 BOTTLE, PLASTIC (0378-2302-10) | Prazosin Hydrochloride | Mylan Pharmaceuticals Inc. | 1989-02-28 |
| 00378-3205-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-3205-01) | Prazosin Hydrochloride | Mylan Pharmaceuticals Inc. | 1989-02-28 |
| 00378-3205-25 | 250 CAPSULE in 1 BOTTLE, PLASTIC (0378-3205-25) | Prazosin Hydrochloride | Mylan Pharmaceuticals Inc. | 1989-02-28 |
| 00527-4180-37 | 100 CAPSULE in 1 BOTTLE (0527-4180-37) | Prazosin | Lannett Company, Inc. | 2024-01-03 |
| 00527-4180-43 | 1000 CAPSULE in 1 BOTTLE (0527-4180-43) | Prazosin | Lannett Company, Inc. | 2024-01-03 |
| 00527-4181-37 | 100 CAPSULE in 1 BOTTLE (0527-4181-37) | Prazosin | Lannett Company, Inc. | 2024-01-03 |
| 00527-4181-43 | 1000 CAPSULE in 1 BOTTLE (0527-4181-43) | Prazosin | Lannett Company, Inc. | 2024-01-03 |
| 00527-4182-37 | 100 CAPSULE in 1 BOTTLE (0527-4182-37) | Prazosin | Lannett Company, Inc. | 2024-01-03 |
| 00527-4182-42 | 250 CAPSULE in 1 BOTTLE (0527-4182-42) | Prazosin | Lannett Company, Inc. | 2024-01-03 |
| 00615-8519-39 | 30 CAPSULE in 1 BLISTER PACK (0615-8519-39) | Prazosin Hydrochloride | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-08-13 |
| 00615-8520-39 | 30 CAPSULE in 1 BLISTER PACK (0615-8520-39) | Prazosin Hydrochloride | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-08-13 |
| 00904-7020-61 | 100 BLISTER PACK in 1 CARTON (0904-7020-61) / 1 CAPSULE in... | Prazosin Hydrochloride | Major Pharmaceuticals | 2018-10-03 |
| 00904-7021-61 | 100 BLISTER PACK in 1 CARTON (0904-7021-61) / 1 CAPSULE in... | Prazosin Hydrochloride | Major Pharmaceuticals | 2018-10-03 |
| 00904-7022-61 | 100 BLISTER PACK in 1 CARTON (0904-7022-61) / 1 CAPSULE in... | Prazosin Hydrochloride | Major Pharmaceuticals | 2018-10-03 |
| 10135-0666-01 | 100 CAPSULE in 1 BOTTLE (10135-666-01) | Prazosin Hydrochloride | Marlex Pharmaceuticals Inc | 2018-10-01 |
| 10135-0666-10 | 1000 CAPSULE in 1 BOTTLE (10135-666-10) | Prazosin Hydrochloride | Marlex Pharmaceuticals Inc | 2018-10-01 |
| 10135-0667-01 | 100 CAPSULE in 1 BOTTLE (10135-667-01) | Prazosin Hydrochloride | Marlex Pharmaceuticals Inc | 2018-10-01 |
| 10135-0667-10 | 1000 CAPSULE in 1 BOTTLE (10135-667-10) | Prazosin Hydrochloride | Marlex Pharmaceuticals Inc | 2018-10-01 |
| 10135-0668-01 | 100 CAPSULE in 1 BOTTLE (10135-668-01) | Prazosin Hydrochloride | Marlex Pharmaceuticals Inc | 2018-10-01 |
| 10135-0668-69 | 250 CAPSULE in 1 BOTTLE (10135-668-69) | Prazosin Hydrochloride | Marlex Pharmaceuticals Inc | 2018-10-01 |
| 43063-0260-30 | 30 CAPSULE in 1 BOTTLE, PLASTIC (43063-260-30) | Prazosin Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 2010-06-23 |
| 46708-0691-31 | 100 CAPSULE in 1 BOTTLE (46708-691-31) | PRAZOSIN HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2023-03-09 |
| 46708-0691-61 | 250 CAPSULE in 1 BOTTLE (46708-691-61) | PRAZOSIN HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2023-03-09 |
| 46708-0691-91 | 1000 CAPSULE in 1 BOTTLE (46708-691-91) | PRAZOSIN HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2023-03-09 |
| 46708-0692-31 | 100 CAPSULE in 1 BOTTLE (46708-692-31) | PRAZOSIN HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2023-03-09 |
| 46708-0692-61 | 250 CAPSULE in 1 BOTTLE (46708-692-61) | PRAZOSIN HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2023-03-09 |
| 46708-0692-91 | 1000 CAPSULE in 1 BOTTLE (46708-692-91) | PRAZOSIN HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2023-03-09 |
| 46708-0693-31 | 100 CAPSULE in 1 BOTTLE (46708-693-31) | PRAZOSIN HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2023-03-09 |
| 46708-0693-61 | 250 CAPSULE in 1 BOTTLE (46708-693-61) | PRAZOSIN HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2023-03-09 |
| 46708-0693-91 | 1000 CAPSULE in 1 BOTTLE (46708-693-91) | PRAZOSIN HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 2023-03-09 |
| 48433-0084-20 | 100 BLISTER PACK in 1 CARTON (48433-084-20) / 1 CAPSULE in... | Prazosin Hydrochloride | Safecor Health LLC | 2026-03-25 |
| 48433-0085-20 | 100 BLISTER PACK in 1 CARTON (48433-085-20) / 1 CAPSULE in... | Prazosin Hydrochloride | Safecor Health LLC | 2026-03-25 |
| 48433-0086-20 | 100 BLISTER PACK in 1 CARTON (48433-086-20) / 1 CAPSULE in... | Prazosin Hydrochloride | Safecor Health LLC | 2026-03-25 |
| 51079-0630-20 | 100 BLISTER PACK in 1 CARTON (51079-630-20) / 1 CAPSULE in... | Prazosin Hydrochloride | Mylan Institutional Inc. | 1998-10-05 |
| 51079-0631-20 | 100 BLISTER PACK in 1 CARTON (51079-631-20) / 1 CAPSULE in... | Prazosin Hydrochloride | Mylan Institutional Inc. | 1998-10-06 |
| 51079-0632-20 | 100 BLISTER PACK in 1 CARTON (51079-632-20) / 1 CAPSULE in... | Prazosin Hydrochloride | Mylan Institutional Inc. | 1998-10-06 |
| 59651-0271-01 | 100 CAPSULE in 1 BOTTLE (59651-271-01) | Prazosin Hydrochloride | Aurobindo Pharma Limited | 2023-03-31 |
| 59651-0271-99 | 1000 CAPSULE in 1 BOTTLE (59651-271-99) | Prazosin Hydrochloride | Aurobindo Pharma Limited | 2023-03-31 |
| 59651-0272-01 | 100 CAPSULE in 1 BOTTLE (59651-272-01) | Prazosin Hydrochloride | Aurobindo Pharma Limited | 2023-03-31 |
| 59651-0272-99 | 1000 CAPSULE in 1 BOTTLE (59651-272-99) | Prazosin Hydrochloride | Aurobindo Pharma Limited | 2023-03-31 |
Observed labelers:
ASCLEMED USA INC. (18) ·
Aphena Pharma Solutions - Tennessee, LLC (12) ·
ANI Pharmaceuticals, Inc. (10) ·
Bryant Ranch Prepack (10) ·
Novadoz Pharmaceuticals LLC (10) ·
Alembic Pharmaceuticals Inc. (9)
· +26 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.